Cancer diagnostics is the process of detecting various biomarkers, proteins, and certain symptoms that result in the detection of presence of cancerous tumor in patients. Effective diagnostic testing is used to confirm or eliminate the presence of disease, monitor the disease process, and plan and evaluate the effectiveness of treatment. Diagnostic procedures for cancer may include imaging, laboratory tests (including tests for tumor markers), tumor biopsy, endoscopic examination, surgery, or genetic testing.

Scar is the extra growth of the tissue marking on the spot where skin has healed after the severe or mild injury. The human body naturally heals injuries & cuts, and replaces the damaged skin. Scars are composed of fibrous tissues. It can be formed from various reasons such as injuries, surgeries, skin infection, acne, and the inflammation of the tissue. It can appear anywhere on the body surface. The scar appearance on body depends on the skin type and location, direction of injuries, age of patient/person, and body nutritional status.

The AI in healthcare was introduced back in the 1960s with simple CAD systems for chest X-Ray and mammography applications. In recent years, AI-based systems have shown a stronghold on major technological advancement in the healthcare ecosystem, evolving around patient-centric and value-based care models. According to one of the key vendors of medical imaging Koninklijke Philips N.V., nearly 60% of its research and development activities are dedicated to software, and a large part of these research are on AI.

Virtual reality technology is widely applied in rehabilitation therapy and is termed virtual rehabilitation. VR is a computer-based intervention providing patients with a virtual interactive and applicable treatment setting for skills practice with real-time feedback. Virtual rehabilitation can be used both at home. Most virtual rehabilitation systems developed require motor training which includes complex and expensive hardware and can be used only under professional guidance, such as in hospitals, rehab centers, and clinical settings. Many low-cost rehabilitation gaming systems have been developed for patients with movement disorders. These systems are for home use and require remote supervision of a therapist. The home-use virtual rehabilitation systems promote physical rehabilitation at home and reduce frequent hospital visits, which have reduced healthcare costs.

With the advent of the internet and smartphones, online pharmacies have become a more convenient option for consumers than retail pharmacies, especially in times of a global pandemic, since people can order their medicines from the comfort of their homes using an internet-enabled device. This is also helpful for the elderly and patients who are not able to visit a pharmacy. Moreover, some medications are hard to find in retail pharmacies; hence, online pharmacies make it easier to find and obtain these medications. Retail pharmacies have limited stocks and are expensive, making it difficult for people in rural areas to purchase medicines.

Teleradiology is one of the oldest models of patient consultation, where radiologists use teleradiology to simplify geographical challenges. Many small hospitals that lack adequate facilities to maintain radiology department 24/7 depend on teleradiology which helps provide high-quality interpretations around the clock. End-users of teleradiology services include hospitals, radiology groups, referring physicians, and patients.

Amid the tragic consequences of COVID-19, life sciences and medtech companies emerged as lights in the darkness. Decades of scientific work and investment seemed to be overnight successes. The heroic dedication of health care providers was met by the fastest novel vaccine development in history. Traditional competitors partnered to accelerate research and manufacturing. When one company failed, it joined the other to accelerate the development and manufacture of a successful vaccine. Governments, retail pharmacies, health systems, payers, and nonprofits are working together to provide widespread distribution and administration.

The overall pharma market grew at the forecast compound annual growth rate (CAGR) of 4.7% from 2020–2026, with small molecules and biotech products contributing 43.7% and 30.2%, respectively, to total revenue. Biotech products are expected to drive the growth of the pharma market faster (8.2%) than small molecules (3.0%) between 2020 and 2026. Monoclonal antibodies (Ab) are expected to contribute more than 50% to the biotech product segment.

The report focuses specifically on the devices used in spinal fractures and injuries treatment procedures. These include X-Ray devices and CT devices. The report also includes AI-enabled X-Ray and CT imaging software. The following points highlight the exclusion criteria for the global spine X-Ray and computed tomography market report: Imaging modalities such as MRI, positron emission tomography (PET), ultrasound, and other modalities including single-photon emission computed tomography (SPECT) have not been considered. Imaging devices and software used particularly for the detection of chest X-Rays, lung nodules, cardiovascular diseases, and others have not been considered.

An exoskeleton (or "exoskeleton") is a wearable system that can help a human wearer perform a variety of tasks. The exoskeleton supports normal daily tasks such as walking, carrying objects, going up and down stairs, and general movement when a person's physical fitness is impaired. To date, exoskeleton studies have primarily enabled mobility aids for patients with SCI and medical applications such as rehabilitation for patients with severe trauma, as well as allowing soldiers to march at high speeds and approach heavy equipment.

The global precision cardiology market is currently witnessing several developments, primarily aimed toward bringing new products and services to support the development of advanced genetic tests for cardiovascular diseases (CVDs). Major manufacturers of precision cardiology products and service providers are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting. The following figure depicts the overall key developments undertaken in the global precision cardiology market.

According to John McCarthy, a professor at the Computer Science Department of Stanford University, AI is defined as “the science and engineering of making intelligent machines, especially intelligent computer programs. It is related to the similar task of using computers to understand human intelligence, but AI does not have to confine itself to methods that are biologically observable”.

In an era of cancer immunotherapies, the recent introduction of neoantigen cancer vaccine (also referred neovaccines) has garnered new hope in the medical community, owing to their ability to induce the body’s natural defenses against abnormal malignancies. Cancer is very complex to treat. Sometimes target antigens are also present on normal cells and cancerous cells, making the body vulnerable to attacks in the wrong places by the current mainstays of immunotherapies. Ironically, this phenomenon provides an opportunity for neoantigen cancer vaccine to step in and fill up the potential treatment gaps by selectively targeting cancerassociated antigens. Neoantigens are foreign peptides that are totally absent from the normal healthy cells and are specifically identified by neoantigen-specific T-cell receptors in terms of major histocompatibility complexes (MHCs) molecules. Unlike the tumor-associated antigens and cancer germline antigens, normally present on cancer and healthy cells, neoantigens are exclusively present on the tumor tissues and thus provide an initial concept of targeting them.

Precision medicine is a concept that collectively integrates the outcomes and the endeavors of research and healthcare. The ability to tailor the diagnostics and therapeutics offered to the patients is the key to precision medicine. The combination of biotechnology development, digitization of healthcare, the public investment led to the evolution of the personalization of disease-based therapies. This evolution within precision medicine will profoundly impact the biopharmaceutical industry, and multiple players from biopharma to diagnostics companies with multiple functions such as research and development to commercial operations will witness a change.

With the increase in awareness regarding the harmful effects posed by synthetic chemicals, consumers are now abstaining from using chemical-infused products. In many instances, it has been found that toxic chemicals are being used in low-quality products, hence causing life-threatening problems in some cases. This led to an increase in awareness among consumers across the globe, resulting in an increase in the demand for natural products. The organic and bio-based beauty boom is part of the recent shift in consumer awareness about wellness, health, and the environment. Moreover, due to a growing number of social media influencers and beauty blogs, awareness, and availability of information regarding toxin-free ingredients have significantly risen.

Healthy sex life is a human aspect that has a massive impact on one’s personal and professional life. Continuous efforts are being made to spread awareness regarding sexual wellness among the population globally. With end-users becoming more and more educated, along with incremental advancements in technology that enable society to explore the healthy aspect of their sexual life, the concept of sexual wellness has started to achieve significant recognition worldwide. Factors such as an increase in per capita discretionary income of people globally and a rapidly growing number of dual-income households in developing as well as developed markets are major growth factors for the global sexual wellness market in recent years. Sexual lubricants are a critical part of the sexual wellness market and the factors impacting the sexual wellness industry also impact the sexual lubricants market in several ways.

Conventional minimally invasive surgery has existed for several decades, i.e., since the 1980s. However, the market is constantly being influenced by rapid development in technology, product innovation, and diversification. The rising demand for surgical procedures is primarily attributed to the increasing aging population with one or more chronic disorders. Surgical robotics has been in the market for nearly two decades. The first robotic-assisted surgery system – the da Vinci system manufactured by Intuitive Surgical, Inc., received U.S. FDA approval in 2000. Since then, the market has grown significantly, constantly influenced by technological upgrades. Following is the expected impact on the global market due to key drivers and restraints for the global minimally invasive surgical systems market:

The spine is a column of bone and cartilage that extends from the base of the skull to the pelvis and acts as the core of the human skeleton by supporting the head and the rest of the body. The complexity of the spine structure makes it susceptible to various ailments that can lead to instability and significant low back pain.

Many players in the global AI in operating room market have products and solutions which cater to applications such as scheduling, diagnosis, training, and instrument tracking for most of the indications. However, with time, new market entrants are expected to target niche applications and indications. Given the nature and the early phase of developments in the market, many companies have products in the pipeline, and more new players can be continuing their research and development in stealth mode. Thus, it is to be noted that the current market share of companies is subject to change significantly during the forecast period 2021-2030. The following figure indicates the estimated market shares for key players in the global AI in operating room market.

The global advanced dermatology drug delivery devices market is driven by factors such as the global efforts in increasing the adoption of connected devices, increasing number of business synergies with pharmaceutical companies, novel technologies in drug delivery, and the growing focus on prescription/medication adherence. Manufacturers are more focused on producing devices that offer enhanced patient experience through real-time monitoring and data sharing. The succeeding figure indicates the impact analysis for the different market growth promoting and restraining factors during the forecast period 2021-2030.